✦ LIBER ✦

Effects of once-yearly zoledronic acid 5 mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis

✍ Scribed by F. Cosman⁎; E.F. Eriksen; C. Recknor; P. Miller; S.L. Greenspan; P. Papanastasiou; H. Rao; J. Gasser; C. Bucci-Rechtweg; S. Boonen

Book ID: 116323030
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 168 KB
Volume: 47
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2010.04.104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of once-yearly infusion of zoledr

Effect of once-yearly infusion of zoledronic acid 5mg in postmenopausal women with osteoporosis

✍ Black, Dennis; Lewiecki, E. Micahel; Delmas, Pierre; Eastell, Richard; Reid, Ian 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Poster 150: Effect of Once-Yearly Infusi

Poster 150: Effect of Once-Yearly Infusion of 5mg of Zoledronic Acid in Postmenopausal Women With Osteoporosis: The HORIZON-Pivotal Fracture Trial

✍ Meryl S. LeBoff; Dennis Black; Pierre Delmas; Richard Eastell; Ian Reid; Steve C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Effects of Yearly Zoledronic Acid 5 mg o

Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

✍ Pierre D Delmas; Francoise Munoz; Dennis M Black; Felicia Cosman; Steven Boonen; 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 653 KB

Low Incidence of Osteonecrosis of the Ja

Low Incidence of Osteonecrosis of the Jaw in Postmenopausal Women With Osteoporosis Taking Zoledronic Acid Once Yearly

✍ Cesar A. Migliorati 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Efficacy and Safety of a Once-Yearly Int

Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

✍ Steven Boonen; Dennis M. Black; Cathleen S. Colón-Emeric; Richard Eastell; Jay S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Bone material properties in actively bon

Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid

✍ Sonja Gamsjaeger; Birgit Buchinger; Elizabeth Zwettler; Robert Recker; Dennis Bl 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 473 KB

Zoledronic acid (ZOL), a third-generation aminobisphosphonate, showed pronounced antifracture efficacy in a phase III clinical trial [Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly-Pivotal Fracture Trial (HORIZON-PFT)] when administered yearly (5-mg infusions of ZOL), produci

Effects of once-yearly zoledronic acid 5&#xa0;mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis

Effects of once-yearly zoledronic acid 5 mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis